Dernièrement…

🌱 En direct du Congrès « Natural Products and Biocontrol 2022 » à Perpignan.
Ce matin, notre #BusinessDeveloper a pris la parole lors d’une session dédiée afin de présenter notre agent de #biocontrôle et nos #résultats d’#essais prometteurs sur différentes #cultures agricoles.

📣 Communiqué de Presse : https://bit.ly/3BF5U2B
#Amoéba annonce l’émission de la sixième tranche de 60 obligations convertibles en actions (#OCA) dans le cadre de son #financement obligataire avec programme d’intéressement conclu avec Nice & Green S.A.

🌿Retrouvez les équipes d’#Amoéba au #Congrès Natural Products and Biocontrols 2022 à Perpignan, du 20 au 23 septembre prochain.
Notre #BusinessDeveloper présentera notre solution de #biocontrôle et ses résultats #efficacité sur diverses #cultures devant les experts du domaine.

+70% pour @AmoebaNature alors que l'Agence américaine pour la protection de l'environnement a émis une pré-décision favorable après avoir évalué sa demande d'autorisation de 'Willaertia magna C2c Maky' https://www.boursorama.com/bourse/actualites/amoeba-vers-un-feu-vert-de-l-epa-pour-son-amibe-biocide-59c2a82b84038127133be13ae23167f9?symbol=1rPALMIB

US EPA about to approve Amoéba’s biocide for use in closed cooling systems

Amoéba informs that the US EPA has made a positive pre-decisional determination for the use of Amoéba’s biocide in closed cooling systems

Lyon (France), August 10th, 2022 – 17h45 – AMOÉBA (FR0011051598 – ALMIB), producer of a biological biocide capable of eliminating bacterial risk in water and human wounds, and of a biocontrol product for plant protection, still in development phase, informs that the United States Environmental Protection Agency (US EPA) has made a positive pre-decisional determination following its assessment of the application dossier for the use of Willaertia magna C2c Maky as a biocidal active ingredient in cooling systems. 

The US EPA has concluded that the amoeba Willaertia magna C2c Maky and the BIOMEBA products containing it can be authorized on the United States territory for a biocidal use in closed cooling systems, for the control of microbial slime (bioslime), microbially induced corrosion and general microbial flora in cooling towers waters. 

Based on the last administrative steps required by the US EPA to finalize the procedure, the issuance of the marketing authorization of the products is expected by the end of 2022 at the latest. 

This is historic news that has just been sent to us by the US EPA. Amoéba has been legitimized in its application for the use of a microorganism in the treatment of bacterial risk in water. We will now refine our analysis of the market potential for this type of closed systems. We hope that the pragmatism of North American regulatory agencies will one day inspire European agencies. This decision adds a very positive note to the worldwide interest already in place for our biocontrol application and will influence the company’s future development.”, says Fabrice Plasson, CEO of Amoéba.